Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation

IUBMB Life

Volumn 63, Issue 9, 2011, Pages 772-774

  Hine, David ^a   MacKness, Bharti ^b   MacKness, Mike ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Pontech Art   (Spain)

Author keywords

CETP; HDL; LDL; oxidation

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TORCETRAPIB;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; OXIDATION; VASCULAR DISEASE;

CHOLESTEROL ESTER TRANSFER PROTEINS; HUMANS; INFECTIOUS DISEASE INCUBATION PERIOD; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 80052085912     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.508     Document Type: Article

References (10)

1. Shah, P. K., (2010) Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL. Curr. Opin. Cardiol. 25, 603-608
2. Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J., et al. (2007) Effect of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109-2122. (Pubitemid 350146106)
3. Nissen, S. E., Tardiff, J. C., Nicholls, S. J., Revkin, J. H., Shear, C. L., et al. (2007) Effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. 356, 1304-1316. (Pubitemid 46513296)
4. Mackness, M. I., Abbott, C. A., Arrol, S., and, Durrington, P. N., (1993) The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294, 829-835.
5. Mackness, M. I., and, Durrington, P. N., (1992) Lipoprotein separation and analysis for clinical studies. In Lipoprotein Analysis: A Practical Approach (, Converse, C. A., and, Skinner, E. R., eds.). pp. 1-42, IRL Press, Oxford.
6. Lagrost, L., and, Barter, P., (1991) Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim. Biophys. Acta 1085, 209-216.
7. Mackness, M. I., Arrol, S., and, Durrington, P. N., (1991) Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett. 286, 152-154.
8. Klimov, A. N., Nikiforova, A. A., Kuzmin, A. A., Kuznetsov, A. S., and, Mackness, M. I., (1998) Is high-density lipoprotein a scavenger for oxidised phospholipids of low density lipoprotein. In Proceedings of the 9th Dresden Lipid Symposium. pp. 78-82, Gustave Fischer Verlag, Jena.
9. Christison, J., Karjalaineu, A., Brauman, J., Bygrove, F., and, Stocker, R., (1996) Rapid reduction and removal of HDL but not LDL-associated cholesterylester hydroperoxides by rat liver perfused in situ. Biochem. J. 314, 737-742.
10. Kontush, A., and, Chapman, M. J., (2010) Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr. Opin. Lipidol. 21, 312-318.